Analysis Field Trip white paper makes strong health and business case for ketamine therapy With solid efficacy and low cost, the popular club drug could help curb the personal toll and multi-billion dollar cost of North America's battle... Natalia Buendia CalvilloFebruary 9, 2021
Canada Proposed amendment could greatly expand access to psychedelic therapy in Canada Proposed by Health Canada, the change would allow patients to access restricted substances like MDMA through the Special Access Program Natalia Buendia CalvilloJanuary 28, 2021
Health and Safety What Measure 109 means for the future of psychedelic therapy After a successful ballot measure, a broad set of onlookers focuses on Oregon to gauge the social and economic impacts of licensed psilocybin therapy Amna ShamimDecember 15, 2020
The weed wire UC Berkeley’s new psychedelic research centre wants to change your mind The new hub will focus on the rapidly advancing field by adding unique public education and spiritual components Jared GnamSeptember 16, 2020
The weed wire Mushroom company Mydecine acquires veteran-focused psychedelic firm With deep Canadian and U.S. military ties, NeuroPharm Inc. is about to launch psychedelic-based clinical trials Jared GnamJuly 15, 2020
Medical and Pharmaceutical Canada could regulate psychedelic therapy within few years, bets company Numinus Wellness goes public on the prediction that regulation is coming Michelle GamageMay 22, 2020